APOTHEEK TINE MARTENS
ActiveAPOTHEEK TINE MARTENS has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €180k and a net result of €55k. Equity remains stable across the filed fiscal years (±0.1% per year). Its solvency ranks better than 24% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
71
/ 100
Healthy▲ +26 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+100
Solvency31▼-1
Growth78▲+46
Stability100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity tight (current ratio 1.44 against 1.55 in 2024), and 85.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
14.4%
Return on assets
4.4%
Age of the figures
8 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 10242 sector peers (2025).
NBB · sector comparisonPosition among 10242 sector peers
Solvency
better than 24%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
14 d late
2024
28 d late
2023
30 d late
2022
30 d late
2021
2 d early
2020
52 d late
2019
91 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€180k▲ 5.0%
2024 · €172k
2018: €176k
2019: €177k
2020: €179k
2021: €180k
2022: €131k
2023: €177k
2024: €172k
2018 → 2025
Total assets
€1.25M▼ 4.2%
2024 · €1.30M
2018: €290k
2019: €342k
2020: €380k
2021: €441k
2022: €655k
2023: €800k
2024: €1.30M
2018 → 2025
Net result
€55k
2024 · €-5k
2018: €28k
2019: €41k
2020: €10k
2021: €65k
2022: €-49k
2023: €45k
2024: €-5k
2018 → 2025
Working capital
€149k▼ 14.4%
2024 · €174k
2018: €164k
2019: €179k
2020: €221k
2021: €175k
2022: €122k
2023: €364k
2024: €174k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€180k-€131k▼ 27.1%€177k▲ 34.6%€172k▼ 2.8%€180k▲ 5.0%
Operating result€65k-€-26k€58k€11k▼ 81.6%€83k▲ 679%
Net result€65k-€-49k€45k€-5k€55k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 679% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.25M
Fixed assets
€766k▼ 6.0%
Current assets
€483k▼ 1.2%
Equity and liabilities €1.25M
Equity
€180k▲ 5.0%
Debt
€1.07M▼ 5.6%
The debt ratio falls from 86.8% to 85.6%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€139k▲
2024 · €41k
Cash flow
€110k▲
2024 · €25k
Solvency
14.4%▲
2024 · 13.2%
Current ratio
1.44▼
2024 · 1.55
Quick ratio
0.85▼
2024 · 1.01
Debt / equity
5.93▼
2024 · 6.59
ROE
30.4%▲
2024 · -2.9%
ROA
4.4%▲
2024 · -0.4%
Interest coverage
6.78▲
2024 · 2.28
Debt
€1.07M▼
2024 · €1.13M
Debt ≤ 1 year
€334k▲
2024 · €315k
Debt > 1 year
€728k▼
2024 · €779k
Income taxes
€10k▲
2024 · €0
Staff costs
€56k▲
2024 · €50k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.30M€1.25M▼
Fixed assets21/28€815k€766k▼
Tangible fixed assets22/27€815k€766k▼
Land and buildings22€481k€464k▼
Plant, machinery and equipment23€311k€284k▼
Furniture and vehicles24€23k€17k▼
Current assets29/58€489k€483k▼
Stocks and contracts in progress3€172k€200k▲
Stocks30/36€172k€200k▲
Amounts receivable within one year40/41€103k€127k▲
Trade receivables40€85k€115k▲
Other amounts receivable41€18k€12k▼
Cash at bank and in hand54/58€201k€142k▼
Deferred charges and accrued income490/1€13k€14k▲
Equity and liabilities
Total equity and liabilities10/49€1.30M€1.25M▼
Equity10/15€172k€180k▲
Contributions10/11€19k€19k=
Reserves13€161k€162k▲
Distributable reserves133€161k€162k▲
Profit (loss) carried forward14€-8k€0▲
Amounts payable17/49€1.13M€1.07M▼
Amounts payable after more than one year17€779k€728k▼
Financial debts170/4€704k€653k▼
Other amounts payable178/9€75k€75k=
Amounts payable within one year42/48€315k€334k▲
Current portion of amounts payable after more than one year42€50k€51k▲
Trade debts44€96k€74k▼
Suppliers440/4€96k€74k▼
Taxes, remuneration and social security45€15k€13k▼
Taxes450/3€6k€3k▼
Remuneration and social security454/9€8k€10k▲
Other amounts payable47/48€154k€197k▲
Accrued charges and deferred income492/3€38k€6k▼
Income statement
Code20242025
Remuneration, social security and pensions62€50k€56k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€30k€56k▲
Other operating charges640/8€3k€4k▲
Gross operating margin9900€94k€200k▲
Operating profit (loss)9901€11k€83k▲
Financial income75/76B€2k€2k▼
Recurring financial income75€2k€2k▼
Financial charges65/66B€18k€21k▲
Recurring financial charges65€18k€21k▲
Profit (loss) for the period before taxes9903€-5k€65k▲
Income taxes67/77€0€10k▲
Profit (loss) for the period9904€-5k€55k▲
Profit (loss) for the period to be appropriated9905€-5k€55k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-8k€46k▲
Profit (loss) brought forward from the previous period14P€-3k€-8k▼
Transfer to equity691/2-€250
To other reserves6921-€250
Profit to be distributed694/7-€46k
Return on contributions (dividend)694-€19k
Directors or managers695-€24k
Other beneficiaries697-€4k
Social balance
Average headcount (FTE)90870.80.9▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 14 days late
2025
31-12
Financial
Back to profitnet €55k
Net result €55k after one loss-making year.
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 28 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
31-12
Financial
Back to profitnet €45k
Net result €45k after one loss-making year.
31-12
Financial
Equity above €150kEq €177k ▲34.6%
Equity rises from €131k to €177k.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 30 days late
2022
31-12
Financial
Weakest financial yearnet €-49k ▼175%
Net result drops to €-49k, the lowest in the series; recovery starts the following year.
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €65k ▲579%
Net result €65k, the highest in the series.
21-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 52 days late
2020
30-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 91 days late
2019
03-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
04-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hechtel-Eksel · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Groenstraat 163940 Hechtel-EkselGround area
1,538 m²
Building footprint
6 m²
Parcel 72006A0369/00W000, Flanders. Linked by address, not a title deed.
1 establishment unit
APOTHEEK DE ZORGHOEK
since 20042.135.399.075
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72006A0369/00W000 | Flanders | 1,538 m² | 1 · 6 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 to 2025 · 3 entries · 164 EUR awarded · 164 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 36 EUR | 36 EUR |
| 2024 | 1 | 80 EUR | 80 EUR |
| 2023 | 1 | 48 EUR | 48 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteHechtel-Eksel2.135.399.075
Similar companies · same sector, comparable size
FARMAFLEUR
BE 0894.786.891
Antwerpen · Eq €180k
CARO PHARMA
BE 0899.338.864
Erquelinnes · Eq €180k
PHARMACIE DE NEEF - DUEZ
BE 0445.987.390
Mons · Eq €180k
APOTHECA
BE 0633.956.267
Sint-Joost-ten-Node · Eq €180k
AP'ART
BE 0849.985.165
Gent · Eq €180k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,570 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-12-2003
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.